Wave Life Sciences, Inc. (WVE) stock forecast and price target
Price $3.13 · data as of November 13, 2026
12-month price target
Average target$16.63
Upside / downside+431.4%
Analysts19
ConsensusStrong buy
Low $10.00Average $16.63High $44.00
Gold marker: average target · white marker: today’s price ($3.13)
Analyst ratings
Strong buy 2Buy 17Hold 2Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.10 | +9.3% | $63M |
| Next fiscal year ends December 31, 2027 | $-1.17 | −6.5% | $37M |
| Next quarter ends December 31, 2026 | $-0.32 | −6.9% | $9M |
| Quarter after ends March 31, 2027 | $-0.35 | −168.1% | $9M |
Consensus of the analysts covering Wave Life Sciences, updated daily. In the last 30 days 8 estimates were raised and 3 lowered.
Frequently asked questions
What is the Wave Life Sciences stock price target?
The average 12-month target from 19 analysts is $16.63, 431.4% above the current price of $3.13 Targets range from $10.00 to $44.00.
Is Wave Life Sciences a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 17 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Wave Life Sciences expected to earn?
Analysts expect EPS of $-1.10 for the fiscal year ending December 31, 2026 and $-1.17 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.